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Objective: Determine prevalence of vitamin D deﬁciency (VDD) in a diverse group of women presenting for obstetrical care at
two community health centers in South Carolina at latitude 32◦N. Methods and Design: Any pregnant woman presenting for care
at 2 community health centers was eligible to participate. Sociodemographic and clinical history were recorded. A single blood
sample was taken to measure circulating 25(OH)D as indicator of vitamin D status [25(OH)D < 20ng/mL (50nmol/L deﬁciency;
<32ng/mL (80nmol/L) insuﬃciency]. Total serum calcium, phosphorus, creatinine, and intact parathyroid hormone also were
measured. Results: 559 women, [mean age 25.0 ± 5.4 (range 14–43) years] participated: African American (48%), Hispanic
(38%), Caucasian/Other (14%). Mean gestational age was 18.5 ± 8.4 (median 14.6, range 6.4–39.6) weeks’ gestation. 48% were
VDD; an additional 37% insuﬃcient. Greatest degree was in the African American women (68% deﬁcient; 94% insuﬃcient). In
multivariable regression, 25(OH)D retained a signiﬁcantnegative associationwith PTH (P<. 001).Conclusions:V D Dw a sh i g hi n
adiversegroupofwomen,greatestinthoseofdarkerpigmentation.Thenegativecorrelationbetween 25(OH)DandPTHconﬁrms
their corroborative use as biomarkers of VDD. These ﬁndings raise the issue of adequacy of current vitamin D recommendations
for pregnant women.
1.Introduction
Much has happened in the world of vitamin D research
since the 2002 Centers for Disease Control report of the
widespread deﬁciency in African-American women in their
childbearing years [1]. Vitamin D is no longer seen as just a
“childhood” vitamin that has little bearing on health beyond
bone and calcium metabolism [2–4]. Rather, vitamin D
is now seen as a preprohormone whose active metabolites
act not only to ensure calcium homeostasis and bone
health [5] but also act as mediators of immune function
in general [6, 7], and speciﬁc to pregnancy, play a role
in immune tolerance, insulin resistance, and preeclampsia
[8–12]. Studies to support this premise have increased
signiﬁcantly in number during the past ﬁve years [13–
30], and with frequent lay press articles and featured news
items about vitamin D, public understanding of vitamin D’s
importance in maintaining health has increased. Yet, even
with this understanding, the translation of this knowledge
intoclinicalpracticeinthecommunityisstillminimal. Much
oftheworkconcerningpregnantwomenhasbeenperformed
at university-based clinics, whose relevance to community2 International Journal of Endocrinology
health centers is often in question. Earlier reports of vitamin
D deﬁciency during pregnancy have focused on women
living in northern Europe (latitude 50–55◦N), which did not
include women of diverse racial/ethnic backgrounds living
in a sun-rich environment [5, 31, 32]. Theoretically, women
at lower latitudes, despite darker pigmentation, should have
less vitamin D deﬁciency because of the greater likelihood of
eﬀective sunlight exposure to induce endogenous vitamin D
synthesis [33].
As a result of the concern regarding the prevalence
of vitamin D deﬁciency among pregnant women receiving
care at community health centers, and to clarify earlier
scientiﬁc studies which reported that a majority of African-
American and Hispanic women are vitamin D deﬁcient [34–
40], a cross-sectional study of pregnant women presenting
at a community health center network in South Carolina
at latitude 32◦N was designed and implemented. The aim
of this study was to deﬁne the prevalence of vitamin D
deﬁciency in a large and ethnically diverse cross-sectional
sample of pregnant women living in a sun-rich environment
with ample access to sunlight during most of the year. It
washypothesized thatdespiteSouthCarolina’slowerlatitude
and abundance of sunlight, given modern-day lifestyles
that often preclude sunlight exposure, the majority of the
women presenting for obstetrical care at this community
health center network would have vitamin D insuﬃciency
and a signiﬁcant number would have outright vitamin D
deﬁciency.
2.Methodsand StudyDesign
2.1. Subjects. The study was approved by MUSC’s Institu-
tional Review Board for Human Research (HR# 16476) and
the Palmetto Baptist Hospital Institutional Review Board for
Human Research (PH IRB# 2007-25). The only inclusion
criteria were age of 14 years or more, and conﬁrmed
pregnancy at the time of the clinic visit to one of two urban
community health networks in Columbia and Charleston,
SC. There were no exclusion criteria for participation in the
study. This study was conducted from November 21, 2006
through October 31, 2008.
2.2. Procedure. After providing written informed consent,
women were asked a series of questions about their
sociodemographic characteristics, including self-described
race/ethnicity and health status. Sociodemographic and
clinical characteristics and obstetrical history were recorded
for each woman on a standardized data form. Each woman
had been prescribed a prenatal vitamin containing 400IU
of vitamin D at her ﬁrst prenatal visit; compliance with
the prenatal vitamin regimen at the time of the blood
sampling was also recorded. A blood sample was drawn
with the gestational age (weeks) recorded at the time of the
blood sampling. Blood was processed and serum separated
for later analysis for total circulating 25-hydroxy-vitamin
D [25(OH)D], serum calcium, phosphorus, and creatinine,
and intact parathyroid hormone (PTH). Season was cal-
culated from the date that the blood sample was drawn
according to the following categories: winter, December-
March; spring, April-May; summer, June-September; fall,
October-November.
2.3. Sociodemographic Characteristics of the Cohort. Sociode-
mographic data were collected on each subject using a
standardized dataentryform.Speciﬁcally,informationabout
maternal age, self-identiﬁed ethnicity, health insurance sta-
tus, marital status, employment status, and educational
status was collected. Given the putative relationship between
cigarette smoking and PTH [41, 42], information also
was collected about cigarette smoking during the current
pregnancy.
2.4. Clinical Characteristics of the Cohort. Clinical character-
istics included gravidity, parity, and history of preterm birth,
preeclampsia, and gestational diabetes during prior preg-
nancies. Information regarding maternal history of diabetes
(type 1 or 2) and chronic hypertension was also recorded.
The body mass index (or BMI; kg/m2) was calculated for
each woman based on her prepregnancy weight. Women
with a prepregnancy BMI equal to or greater than 30 were
considered obese.
2.5.Degree of SkinPigmentation. The degreeof skinpigmen-
tation at each of four body sites (forehead, inner underarm,
forearm and knee) was recorded using the Smart Probe 400
(IMS, Inc., Milford, CT) and a skin tone chart (IMS, Inc.) on
a continuous scale from 0–100,where absolute black is 0 and
absolute white is 100.
2.6. Measurement of 25(OH)D. Total circulating 25(OH)D
concentrations (ng/mL) were measured using a commer-
cially available radioimmunoassay (RIA) performed in the
laboratory of Dr. Bruce Hollis (Diasorin, Stillwater, MN).
This laboratory participated throughout the study in the
DEQAS quarterly quality control program for vitamin
D. Ap r i o r i , “deﬁciency” was deﬁned as a concentration
<20ng/mL (<50nmol/L) and “insuﬃciency” as a concentra-
tion between 20 and 32ng/mL (50–80nmol/L) [43].
2.7. Measurement of Parathyroid Hormone (PTH). Intact
parathyroid hormone (pg/mL) was measured by a com-
mercially available immunoradiometric assay (N-Tact PTH
IRMA; Diasorin, Stillwater, MN) following the manufac-
turer’s guidelines.
2.8. Statistical Analysis. Continuous and ordinal demo-
graphic and clinical characteristics were reported as
mean ±SD and median (range). Categorical variables were
reported as frequency and percent. Characteristics were
tabulated for the entire cohort and according to self-
reported race/ethnicity (African-American, Hispanic, Cau-
casian/Other).
The primary endpoint for this study was total circu-
lating 25(OH)D (ng/mL). Secondary endpoints included
serum PTH (pg/mL), calcium (mg/dL), creatinine (mg/dL),
and phosphorus (mg/dL). The associations between theseInternational Journal of Endocrinology 3
continuous endpoints and sociodemographic and clinical
characteristics were examined using multivariable linear
regression, loess regression, and the Kruskal-Wallis test.
Participants were categorized as vitamin D deﬁcient, insuf-
ﬁcient, or suﬃcient as described above; the associations
between vitamin D category and predictive factors were
evaluated using the chi-square test or Fisher’s exact test
(categorical predictors) and logistic regression (continuous
predictors and/or multivariable models). Results were con-
sidered statistically signiﬁcant for P- v a l u e sl e s st h a n. 0 5 .A l l
analyseswereperformedusingSASVersion9.1(SASInstitute
Inc., Cary, NC).
3.Results
As shown in Table 1, 559 women recruited from two com-
munity health center networks in Columbia and Charleston,
SC at latitude 32◦N participated in the study; 4 participants
enrolledtwice duetorepeated pregnanciesduring theenroll-
ment period. The mean age was 25.0 ± 5.4 (range 14–43)
years. The self-reported ethnicities of the participants were
African-American (48.1%), Hispanic (38.1%), Caucasian
(9.5%) and Other (Asian and American Indian) (4.3%).
No participants younger than age 17 reported having a
high school diploma or higher education. The earliest age
reported for each category of education was high school, 17
years; some college, 18 years; associate degree or higher, 19
years. Of the participants aged 17 years or greater, 73.3%
reported at least a high school diploma. Of those aged 18
years or greater, 34.8% reported at least some college. Of
those age 19 years or greater, 9.8% reported achieving an
a s s o c i a t e ’ sd e g r e eo rh i g h e r( P<. 001 for association with
race/ethnicity). Women in this cohort were more likely to
haveno insurance (36.3%)orMedicaid(44.7%)than tohave
private insurance (P<. 001 for association with race). The
majorityoftheparticipants(55.1%)wereenrolledduringthe
summer months (June–September).
A total of252 women (45.1%) were employedat the time
of the study, working a median number of 39 hours worked
perweek (range0–84).Atotalof88(15.7%)reported having
stopped their employment due to pregnancy. In addition, 44
(7.9%) of the study participants were students at the time of
enrollment into the study.
A total of 557 of the 559 participants completed the
clinical characteristics survey. For the majority of women
in the cohort, pregnancy was unplanned (64.9%, P<. 001
for association with race). The overall median self-rated
health status of the women at the time of enrollment was 9
(excellent), and ranged from 3–10 (mean±SD, 8.8 ± 1.2).
A total of 190 (34%) were primigravid women. The median
number of prior pregnancies in the cohort was 1. Of the 367
womenwithastatedhistoryofapriorpregnancy,159(28.4%
total cohort) had 1 prior pregnancy, 97 (17.4% total cohort)
had 2 prior pregnancies, and 111 (19.9% total cohort) had
≥3 prior pregnancies. Of those women with a history of
one or more prior pregnancies, 41 (7.3% total cohort)
had a history of preterm birth. In addition, preeclampsia
w a sr e p o r t e di nap r i o rp r e g n a n c yi n2 1( 3 . 8 % )w o m e n ,
and gestational diabetes was reported in 15 (2.7%) women.
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Figure 1: Baseline circulating 25(OH)D levels (ng/mL).
A small percentage (5.2%) of the women reported dietary
restrictions that may have inﬂuenced their vitamin D status;
3% reported such restrictions for health reasons such as type
2 diabetes, 0.9% for religious reasons (vegetarian), and 1.3%
gave no reason.
The mean vitamin D status of the cohort, as measured
by total circulating 25(OH)D, was 21.7 ± 9.7ng/mL (range
3.8 to 73.8; unavailable for 7 participants). Overall, 48% of
the participants were vitamin D deﬁcient, with an additional
37.1% insuﬃcient. As shown in Figure 1,t h i sv a r i e d
signiﬁcantly by self-identiﬁed race/ethnicity (P<. 001). The
greatest degrees of deﬁciency and insuﬃciency were seen
in the African-American women, with 68.3% having frank
deﬁciency (concentration <20ng/mL) and 94.3% having
eitherdeﬁciencyorinsuﬃciency(concentration<32ng/mL).
Table 2 provides additional details regarding the prevalence
of the degrees of deﬁciency by race/ethnicity. In univariate
logistic regression models, African-American women had
approximately 8 times the odds of vitamin D deﬁciency
of Hispanic women, and 20 times the odds of vitamin
D deﬁciency of Caucasian women (P<. 001 for both
comparisons). Vitamin D status as measured by 25(OH)D
was also analyzed by season: after controlling for race, there
was no signiﬁcant evidence of seasonal variation in the
prevalence of vitamin D insuﬃciency and/or deﬁciency in
this population.
The mean gestational age was 18.5 ± 8.4 (median 14.6,
range 6.4–39.6) weeks of gestation (see Table 1). As shown
in Table 5, a total of 56.0% of the cohort were less than
16 weeks of gestation, 24.7% were between 16 and 28
weeks of gestation, and 17.2% were at 28 weeks or more
of gestation (0.9% did not report a gestational age). The
odds of vitamin D deﬁciency (as measured by 25(OH)D
concentration) did not appear to change as a function of4 International Journal of Endocrinology
Table 1: Sociodemographic and clinical characteristics at time of enrollment, by self-reported race/ethnicity.
Sociodemographic and clinical
characteristics
Total cohort
N = 559
African-American
N = 269
Hispanic
N = 213
Caucasian
N = 53
Other ethnicities
N = 24 P-value
Maternal age∗
(Mean±SD) 25.0±5.4 23.9±5.1 26.1±5.4 25.8±5.7 26.8±5.7 <.001
Gestational age∗
(Mean±SD) 18.5±8.4 18.0±8.0 19.2±9.0 17.7±7.8 19.3±8.2 .49
Highest education achieved
<High school 155 (28%) 43 (16%) 102 (48%) 8 (15%) 2 (8%)
High school 215 (38%) 100 (37%) 90 (42%) 18 (34%) 7 (29%)
Some college 138 (25%) 101 (38%) 15 (7%) 16 (30%) 6 (25%) <.001
Assoc. degree or higher 51 (9%) 25 (9%) 6 (3%) 11 (21%) 9 (38%)
Employment (yes) 252 (45%) 149 (55%) 68 (32%) 28 (53%) 7 (29%) <.001
Insurance status
None 203 (36%) 4 (1%) 189 (89%) 3 (6%) 7 (29%)
Medicaid 250 (45%) 207 (77%) 12 (6%) 23 (43%) 8 (33%) <.001
Private 106 (19%) 58 (22%) 12 (6%) 27 (51%) 9 (38%)
Subjective health rating scale
(Median, range)∗∗ 9
3–10
9
3–10
9
3–10
9
7–10
10
6–10 .040
Prior obstetrical history
Preterm birth 41 (7.3%) 27 (10.0%) 11 (5.2%) 2 (3.8%) 1 (4.2%) .17
Preeclampsia 21 (3.8%) 13 (4.8%) 5 (2.4%) 2 (3.8%) 1 (4.2%) .48
Gestational diabetes 15 (2.7%) 9 (3.4%) 3 (1.4%) 2 (3.8%) 1 (4.2%) .30
Diabetes Mellitus (type 1 or 2) 8 (1.4%) 6 (2.2%) 2 (0.9%) 0 0 .64
Chronic hypertension 21 (3.8%) 15 (15.6%) 1 (1.9%) 3 (1.4%) 2 (8.3%) .036
Planned pregnancy 196 (35%) 43 (16%) 121 (57%) 21 (40%) 11 (46%) <.001
Primigravida† 190 (34.1%) 98 (36.4%) 65 (30.7%) 19 (36.5%) 8 (33.3%) .59
BMI ≥ 30† 174 (31.1%) 94 (34.9%) 65 (30%) 11 (21%) 4 (17%) .076
Season†
April-May 79 (14.1%) 45 (16.7%) 23 (10.8%) 7 (13.2%) 4 (16.7%) <.0001
June–September 309 (55.3%) 127 (47.2%) 138 (64.8%) 27 (50.9%) 17 (70.8%)
October-November 79 (14.1%) 32 (11.9%) 38 (17.8%) 8 (15.1%) 1 (4.2%)
December–March 92 (16.5%) 65 (24.2%) 14 (6.6%) 11 (20.8%) 2 (8.3%)
P-values refer to the comparison between the four racial/ethnic categories reported.
∗ANOVA; †Chi-square; ∗∗Subjective Health Rating Scale 0=poor to 10=excellent.
Table 2: Prevalence of vitamin D deﬁciency (N, %) according to race/ethnicity.
Deﬁciency category Total cohort
N = 552
African-American
N = 262
Hispanic
N = 213
Caucasian
N = 53
Other Ethnicities
N = 24
<12ng/mL 87 (15.8%) 67 (25.6%) 13 (6.1%) 4 (7.5%) 3 (12.5%)
12–19ng/mL 178 (32.2%) 112 (42.7%) 53 (24.9%) 6 (11.3%) 7 (29.2%)
20–31ng/mL 205 (37.1%) 68 (26.0%) 101 (47.4%) 27 (50.9%) 10 (41.7%)
32+ng/mL 82 (14.9%) 15 (5.7%) 46 (21.6%) 16 (30.0%) 4 (16.7%)
gestational age; women in their later stages of pregnancy had
a similar odds of vitamin D deﬁciency and insuﬃciency for
a given race/ethnicity than women who had their 25(OH)D
concentrations measured earlier in pregnancy (P = .43). A
total of 58 (10.4%) participants reported using prenatal vita-
mins or multivitamins; this was weakly associated with race
(P = .065). After controlling for race, prenatal/multivitamin
use (containing 400IU vitamin D/day) was not associated
with 25(OH)D concentration (P = .11).
We evaluated the use of skin pigmentation score as
a surrogate for race; this resulted in a strong correlation
between 25(OH)D concentration and pigmentation score
(P<. 002 for all measurement sites). As expected, this
association became nonsigniﬁcant when race was added toInternational Journal of Endocrinology 5
Table 3: Multinomial logistic regression model for the univariate associations between vitamin D concentration and age, gravidity, BMI,
race, and season of measurement.
Variable VitaminD group Odds ratio 95% CI P-value
Age < 25
<20 1.35 0.82–2.21 .24
20–31 1.28 0.77–2.14 .35
32+ 1.00 (ref) — —
Primigravida
<20 0.82 0.49–1.38 .45
20–31 0.99 0.58–1.71 .99
32+ 1.00 (ref) — —
Obesity (BMI ≥ 30)
<20 2.19 1.23–3.90 .008
20–31 1.21 0.66–2.22 .54
32+ 1.00 (ref) — —
African-American (versus Caucasian)
<20 20.28 7.91–52.02 <.0001
20–31 2.96 1.29–6.78 .007
32+ 1.00 (ref) — —
Hispanic (versus Caucasian)
<20 2.44 1.03–5.81 .046
20–31 1.44 0.71–2.90 .51
32+ 1.00 (ref) — —
Summer Months
<20 0.60 0.34–1.05 .073
20–31 0.88 0.49–1.59 .67
32+ 1.00 (ref) — —
Odds ratios are univariate (unadjustedfor the other listed covariates); no additional covariates were includedin the model. Vitamin D group sample sizesare
as follows: <20, n = 265; 20–31, n = 205; 32+, n = 82. Missing data were as follows: gravidity (n = 2). The race category of “Other” was excluded from this
analysisdue to small sample size.
the model. A related measure of sun exposure, derived as
the diﬀerence in pigmentation scores between the inner
underarm and forearm, was not associated with 25(OH)D
concentration (P = .27), as both values changed pursuant to
sun exposure.
Multinomial logistic regression models for the three
vitamin D categories (deﬁcient, insuﬃcient, and suﬃcient)
wereconstructedtoevaluatetheassociation betweenvitamin
D status and age, gravidity, race, and season of measure-
ment. The results of these univariate models are described
in Table 3. Speciﬁcally, obesity and race demonstrated a
signiﬁcant association with vitamin D category, and obesity
retained a signiﬁcant relationship with vitamin D category
after controlling for race (P = .01).
The association betweenrelevant priorand current med-
ical conditions and present vitamin D status is summarized
in Table 4. In exploratory univariate analyses, vitamin D
concentrations diﬀered signiﬁcantly or nearly signiﬁcantly
between subgroups based on hypertension (P = .055),
diabetes (P = .023), varicose veins (P = .056), and the
presence of any STD (P<. 001). After controlling for
race, 25(OH)D concentration diﬀered marginally between
subgroups deﬁned by the presence/history of psychiatric
illness (P = .058) and diabetes (P = .074). In all of the
models described in Table 3, race was a highly signiﬁcant
independent predictor of 25(OH)D concentration.
Correlation analysis found that 25(OH)D concentration
was weakly, but signiﬁcantly, associated with serum calcium
(r = 0.12, P = .007) and negatively associated with PTH
(r =− 0.24,P<. 001;see Figure 2) and marginally associated
with serum creatinine (r =− 0.08, P = .055). Fitting of
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Figure 2: Scatterplot of PTH and 25(OH)D concentrations.
The overlaid line modeling the relationship between PTH and
25(OH)D was ﬁt using loess regression (locally weighted smoothed
regression).
a three-parameter exponential decay model suggested that
the inﬂection point at which 25(OH)D and the eﬀect of
higher 25(OH)D had no further eﬀect on PTH, that is, the
relationship reached aplateauwas approximately16.7ng/mL
(95% CI 14.8–18.6ng/mL). There was no evidence of associ-
ation between 25(OH)D and serum phosphorus (r = 0.02,6 International Journal of Endocrinology
Table 4: History of prior or current medical conditions of study participants and 25(OH)D concentrations at time of enrollment.
Medical condition N (%) with history 25(OH)D Concentration of
those with history
25(OH)D Concentration of
those without history P-value
Urinary tract infection 160 (28.6%) 20.7 (8.9) 21.7 (10.3) .27
Abnormal PAP smear 92 (16.5%) 21.0 (11.5) 21.5 (9.6) .62
History of preterm labor or
miscarriage 41 (7.3%) 18.3 (11.2) 21.7 (9.8) .039∗
Anemia 47 (8.4%) 19.5 (7.1) 21.6 (10.2) .16
Asthma 45 (8.1%) 19.6 (8.3) 21.6 (10.1) .21
Psychiatric illness 36 (6.4%) 19.5 (8.1) 21.6 (10.1) .23
Bipolar disorder 5 (0.9%) 23.2 (10.2) 21.4 (10.0) .68
Depression 29 (5.2%) 19.5 (8.1) 21.5 (10.0) .29
Varicose veins 23 (4.1%) 25.3 (13.4) 21.3 (9.8) .056
Hypertension 21 (3.8%) 17.3 (10.9) 21.6 (9.9) .055
Kidney stones and/or
disease 10 (1.8%) 21.7 (6.4) 21.4 (10.0) .93
Diabetes 8 (1.4%) 13.5 (4.5) 21.5 (10.0) .023∗
Seizures 7 (1.3%) 19.5 (8.0) 21.5 (10.0) .61
Tuberculosis 6 (1.1%) 22.4 (5.8) 21.4 (10.0) .81
Thyroid disease 5 (0.9%) 19.8 (11.5) 21.4 (10.0) .71
Any Reported Sexually
Transmitted Disease 126 (22.5%) 18.3 (9.4) 22.3 (9.9) <.001∗
Chlamydia 99 (17.7%) 18.2 (9.8) 22.1 (9.9) .0003∗
Gonorrhea 29 (5.2%) 19.6 (7.8) 21.5 (10.1) .32
Genital herpes 11 (2.0%) 18.1 (9.7) 21.5 (10.0) .26
Genital warts 10 (1.8%) 19.2 (5.7) 21.5 (10.0) .48
P = .70). Controlling for race did not change the association
between 25(OH)D and calcium. In a multivariable model
containing both race and 25(OH)D, race was a signiﬁcant
independent predictor of serum creatinine (P<. 001),
and the association between creatinine and 25(OH)D after
controllingforracewas barelysigniﬁcant (P = .047).Neither
race nor 25(OH)D was associated with serum phosphorus in
a multivariable model.
The overallmean±SDPTHconcentrationwas19.2±8.8
(range 4.7–70.8)pg/mL. As expected, PTH demonstrated
a positive association with gestational age category (see
Table 5; P<. 001). There was no evidence of association
between PTH and race (P = .51; see Table 6(a)). Asshown in
Table 6(b), in a model of PTH, race did not add signiﬁcantly
to the model (P = .66). Similarly, there was no signiﬁcant
interaction between race and gestational age (P = .23),
suggesting that there was no detectable diﬀerence between
races in the association between PTH and gestational age.
These ﬁndings suggest that the positive association between
PTH and gestational age was consistent among racial/ethnic
categories.
A f t e ra c c o u n t i n gf o rt h ee ﬀect of gestational age,
25(OH)D retained a signiﬁcant negative association with
PTH (P<. 001). In addition, there was a trend toward
increased magnitude of association between PTH and gesta-
tional age among participants with lower 25(OH)D (P = .11
for interaction), suggesting that the increase in PTH due
to endogenous production by the placenta is moderated by
25(OH)D across the full range of gestational ages. PTH was
negatively associated with serum calcium (r =− 0.38, P<
.001) even after controlling for gestational age, and weakly
associated with serum phosphorus (r =− 0.11, P = .011);
calcium and phosphorus were also associated (r = 0.25,
P<. 001).
With regard to cigarette smoking, there were 35 women
in the cohort who reported use of cigarettes during the
current pregnancy (6.3%). PTH was signiﬁcantly associated
with reported smoking status (nonsmokers 19.4pg/mL,
smokers 16.6pg/mL, P = .0387). The association between
PTH and gestational age category, however, was unchanged
in eﬀect estimates or signiﬁcance after controlling for
smoking.
4.Discussion
V i t a m i nDd e ﬁ c i e n c yi nw o m e no fd i v e r s ee t h n i cb a c k -
ground, including those of African-American and Hispanic
descent, was prevalent in this cohort, more prevalent than
what has been reported earlier in women of those ethnicities
living at higher latitudes. Overall, 48% of the participants
were vitamin D deﬁcient, with an additional 37% being
insuﬃcient. This degree of deﬁciency was noted despite that
these women lived in a sun-rich climate for most of the year.
Women who reported taking a prenatal vitamin containing
400IU vitamin D did not diﬀer from those who did not in
vitamin D status as measured by 25(OH)D.International Journal of Endocrinology 7
Table 5: Serum 25(OH)D and PTH according to gestationalage.
<15 6/7 weeks
(n = 313)
16–27 6/7 weeks
(n = 138)
28+ weeks
(n = 96) P-value
25(OH)D (ng/mL)
Mean ± SD 21.9±9.7 21.2±9.1 22.2±10.7 .83
Median (range) 20.5 (4.2–73.8) 20.4 (5.1–44.1) 20.4 (3.8–61.3)
PTH (pg/mL)∗
Mean ±SD 16.9±7.2 21.3±9.0 23.9±10.6 <.001
Median (range) 15.7 (4.7–39.5) 20.2 (5.8–48.0) 22.4 (6.6–70.8)
Reported as mean (SD) in row 1, and median (range) in row 2. ∗Missing data (n = 1) for PTH.
Table 6: Intact PTH during pregnancy by race/ethnicity and gestational age at time of measurement.
(a) EstimatedPTH (pg/mL) levels for each category of self-identiﬁed race and ethnicity†
N∗ Mean (SD) Range
All participants 551 19.2 (8.8) 4.7–70.8
African-American 261 19.6 (9.5) 5.1–70.8
Caucasian 53 17.9 (9.1) 6.2–38.7
Hispanic 213 19.1 (8.0) 4.7–40.9
Other 24 18.0 (6.6) 7.6–32.6
†Eight subjects had insuﬃcient blood sample to measure PTH and thus, were excluded from this table.
(b) Serum PTH (pg/mL) according to gestationalage and race/ethnicity∗∗
PTH According to Gestational Age and Race/Ethnicity
<32 weeks
(n = 484)
32–35 weeks
(n = 36)
36+ weeks
(n = 26)
All participants 18.7 (8.5)
17.4 (4.7–70.8)
21.5 (9.1)
22.1 (6.6–44.2)
26.9 (9.6)
27.9 (9.6–45.2)
African-American 19.0 (9.0)
17.3 (5.1–70.8)
22.0 (10.9)
22.8 (6.6–44.2)
32.9 (9.8)
33.2 (17.2–45.2)
Caucasian 17.6 (8.8)
15.3 (6.4–38.7)
20.3 (9.5)
21.7 (10.2–29.1)
27.8 (—)
27.8 (18.2–37.3)
Hispanic 18.5 (8.0)
17.7 (4.7–40.9)
22.6 (7.0)
24.2 (7.0–30.8)
23.1 (7.5)
21.8 (9.6–33.6)
Other 18.5 (6.5)
16.9 (10.7–32.6)
11.8 (—)
11.8 (7.6–16.0)
∗∗Reported as mean (SD) in row 1 and median (range) in row 2. Blank cells are those that contain no participants.SD was not estimatedin cells that contain
fewerthan 3 observations.
While present in Caucasian women, the greatest preva-
lence of deﬁciency was noted in those women of darker
pigmentation, speciﬁcally, African-American and Hispanic
women. While there was a signiﬁcant variation in 25(OH)D
concentrations between racial/ethnic categories, the deﬁ-
ciency did not appear to change as a function of gesta-
tional age; women in their later stages of pregnancy had
a similar risk of vitamin D deﬁciency and insuﬃciency
for a given race/ethnicity compared with women who
had their 25(OH)D concentrations measured earlier in
pregnancy. This suggests that any reductionsin sun exposure
attributable to the limited mobility or lower maternal body
self-image experienced during later stages of pregnancy did
not have a meaningful impact on 25(OH)D concentrations.
Whilewelackspeciﬁcsunexposure data,wehypothesize that
this apparent absence of association may be due to minimal
sun exposure among our participants at all gestational ages,
as reﬂected by their low 25(OH)D status.
Prior studies have reported conﬂicting data about
PTH concentrations during pregnancy. Some investigators
reported that PTH bioactivity during pregnancy is either
in the normal range [44–47]o ri n c r e a s e s[ 48–52];while
others have reported that intact PTH concentration is
approximately half that seen in the nonpregnant woman
[53, 54]. Okonofua et al. [55], in response to these dif-
ferences in study ﬁndings, designed a study to elucidate
PTH activity during pregnancy. In their study of Asian
and Caucasian women in the UK, PTH concentrations
were greater in Asian than Caucasian women, but despite
these diﬀerences, both groups maintained blood calcium
concentrations in the normal range. When both groups
were combined, PTH was inversely related to both plasma8 International Journal of Endocrinology
calcium and 25(OH)D. In contrast, when the groups were
analyzed separately, the inverse correlation between PTH
and calcium persisted whereas the relationship between
PTH and 25(OH)D disappeared. This observation was the
ﬁrst of its kind in the literature. The authors suggested
that this signiﬁcant inverse relationship between calcium
and PTH concentrations in a group of women whose
calcium concentrations were within the normal range was
consistent with the premise that PTH secretion is responsive
to alternations in calcium concentration during pregnancy
irrespective of the underlying trends toward an increase in
PTH during pregnancy.
In our study, while PTH demonstrated a positive asso-
ciation with gestational age, there was no evidence of an
interaction between gestational age and race, which suggests
that the positive association between PTH and gestational
age was consistent among racial/ethnic categories. After
accounting for the eﬀect of gestational age through multi-
variable regression, 25(OH)D status retained a signiﬁcant
negative association with PTH, conﬁrming that even during
pregnancy, PTH is a predictor of vitamin D deﬁciency. Our
results regarding the association between PTH and calcium
were consistent with those of Okonofua et al. [55], from two
decadesago with a populationofwomenof diverse ethnicity.
Using both circulating 25(OH)D and PTH as markers
of vitamin D deﬁciency, these ﬁndings underscore recent
reports of widespread vitamin D deﬁciency among pregnant
women, even in areas of the world with ample sunlight.
This is concerning in that the eﬀects of vitamin D deﬁciency
among pregnancy women are not limited to the women: if
am o t h e rh a sv i t a m i nDi n s u ﬃciency, or worse, deﬁciency,
her fetus is developing in a hypovitaminotic state. At its
most basic concentration, such a burden of deﬁciency sets
the stage of subsequent deﬁciency for the neonate and infant
whose stores of vitamin D were set during pregnancy. Infants
who are vitamin D deﬁcient at birth are at the highest risk
of impaired bone development [5] that appears to persist
in even later childhood [37]. What is most concerning is
that use of prenatal vitamins containing 400IU/tablet was
irrelevant in aﬀecting vitamin D status: those who took their
prescribed prenatal vitamin containing vitamin D did not
diﬀer from those who did not. Women taking their prenatal
vitamins should be counseled that the amount of vitamin
D contained in their prenatal vitamin will not aﬀect their
vitamin D status [33, 56, 57].
The strengths of the study are that a large and diverse
group of women at various stages of pregnancy were studied
to: (1) ascertain their vitamin D status at the time of
presentation to a community health centerand (2) ﬁnd what
factors were most predictive of that status in a sun-rich
environment where theoretically there are no limitations to
achieving an adequatevitamin D status. Potential limitations
of this study include that the active form of vitamin D,
1,25(OH)2D, was not measured. In addition, while maternal
use of prenatal vitamins was recorded, compliance with this
regimen was not ascertained through pill counts. We have
established previously that pill counts are not necessarily
predictive of adherence to protocol and only biochemical
measures give one a true indication of adherence [58].
Given recent discoveries that link vitamin D with the
innate immune system [6], it is not unreasonable to pre-
dict that deﬁciencies during fetal development could have
lasting sequelae on the child, not only in terms of bone
mineralization, but also in terms of immune development
t h a tb e c o m e st h eb a s i sf o rl a t e rd e r a n g e m e n t ss e e nw i t h
long-latency diseases such as multiple sclerosis, rheumatoid
arthritis, diabetes, and certain cancers [59]. However, little
is currently known about the long-term sequelae of fetal
hypovitaminosis D on immune function. Studies to examine
the beneﬁt of higher doses of vitamin D during pregnancy
suggest that the dose of vitamin D found in most prenatal
vitamins—400IU—is inadequate to meet the needs of the
pregnant woman and her growing fetus [11, 32, 34, 39,
60–67]. Taking into account vitamin D’s emerging role
in immune maintenance throughout the body and the
mounting evidence to support the importance of vitamin D
in maintaining good health, at the very least, women who
are deﬁcient in vitamin D should be counseled regarding
the risks of vitamin D deﬁciency for themselves and their
oﬀspring and recommended a therapy to ensure vitamin D
adequacy [60–62, 68–70].
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